RITZA contains Rizatriptan which belongs to the group of medicines called Selective serotonin 5-hydroxytryptamine receptor agonist. RITZA is used in adults to treat headache phase of migraine attack.
RITZA is not recommended for use in patients allergic to Rizatriptan. It is also not recommended for use in patients suffering from moderate/mild/severe high blood pressure (which is not controlled by medication), stroke, peripheral vascular disease (condition marked by blockage of blood vessels), heart problems (such as heart attack, angina), and/or severe kidney/liver problems.
Before taking RITZA, inform your doctor if you have diabetes, family history of heart disease, headache (associated with dizziness, difficulty in walking, lack of coordination), short lived symptoms (such as chest pain, tightness), and/or mild to moderate kidney/liver problems.
RITZA should be used with caution during pregnancy and in women planning for pregnancy only if it is clearly necessary as it is not known whether the medicine can cause harm to the unborn baby. It is also used with caution in breastfeeding women only if it is clearly necessary. Breastfeeding mothers should avoid nursing the child for next 24 hours after taking the medicine since it may cause unwanted effects in the nursing child.
RITZA is not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking RITZA are tingling sensation of hands/feet, headache, sleeplessness, dry mouth, nausea, vomiting, and/or diarrhea. Consult your doctor if any of these symptoms worsens.